Titan is focused on the design, development and commercialization of new robotic surgical technologies. The Company is advancing the development of a robust product portfolio with the objective to meet current needs in surgical procedures which would benefit all stakeholders, including patients, surgeons, and hospitals. The Company currently has under development the SPORT™ Surgical System. Robotic surgery has developed over the past several years into a proven and growing method of treatment. Titan is planning to first commercialize the SPORT Surgical System in Europe followed by the United States, the world’s two largest markets for robotic surgery.
Titan is developing the SPORT Surgical System to address the current clinical, operational and financial limitations of the robotic platforms in the high growth robotic surgery market. The current robotic technology is cost prohibitive for secondary and tertiary hospitals, as well as for ambulatory surgery centers, and is confined to a limited number of surgical procedures, such as hysterectomies and prostatectomies. Titan’s well-differentiated SPORT Surgical System will expand robotic surgery into areas that are currently underserved, including general abdominal, gynecologic, urologic and colorectal procedures, in a cost-effective manner.
Titan is highly responsive to patients and stakeholders’ medical, clinical, operational and financial needs and aims to bring enhanced technology to the market place. The SPORT Surgical System is designed to offer the following competitive advantages: